FI954127A0 - Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa - Google Patents

Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa

Info

Publication number: FI954127A0
Authority: FI; Finland
Prior art keywords: respond; patients; treating hepatitis; interferon therapy; hepatitis
Prior art date: 1993-03-05

Application number

FI954127A

Other languages

English (en)

Swedish (sv)

Other versions

FI954127A (fi

Inventor

Paul B Chretien

Milton Mutchnick

Original Assignee

Alpha 1 Biomedicals Inc

Univ Wayne State

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-05

Filing date

1995-09-04

Publication date

1995-09-04

1993-03-05 Priority claimed from US08/027,500 external-priority patent/US6001799A/en

1995-09-04 Application filed by Alpha 1 Biomedicals Inc, Univ Wayne State filed Critical Alpha 1 Biomedicals Inc

1995-09-04 Publication of FI954127A0 publication Critical patent/FI954127A0/fi

1995-09-04 Publication of FI954127A publication Critical patent/FI954127A/fi

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

FI954127A 1993-03-05 1995-09-04 Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa FI954127A (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/027,500 US6001799A (en)	1991-09-13	1993-03-05	Method of treating hepatitis C in non-responders to interferon treatment
PCT/US1994/002320 WO1994020131A1 (en)	1993-03-05	1994-03-03	Method of treating hepatitis c in non-responders to interferon treatment

Publications (2)

Publication Number	Publication Date
FI954127A0 true FI954127A0 (fi)	1995-09-04
FI954127A FI954127A (fi)	1995-09-04

Family

ID=21838079

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI954127A FI954127A (fi)	1993-03-05	1995-09-04	Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa

Country Status (17)

Country	Link
EP (1)	EP0687181B1 (fi)
JP (1)	JPH06279309A (fi)
KR (1)	KR100306024B1 (fi)
CN (1)	CN1072961C (fi)
AT (1)	ATE204760T1 (fi)
AU (1)	AU683248B2 (fi)
CA (1)	CA2157479C (fi)
DE (1)	DE69428112T2 (fi)
DK (1)	DK0687181T3 (fi)
ES (1)	ES2162862T3 (fi)
FI (1)	FI954127A (fi)
GR (1)	GR3037021T3 (fi)
MY (1)	MY121198A (fi)
NO (1)	NO320877B1 (fi)
PT (1)	PT687181E (fi)
SG (1)	SG64894A1 (fi)
WO (1)	WO1994020131A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2236591C (en)	1995-11-02	2012-01-03	Schering Corporation	Continuous low-dose cytokine infusion therapy
US7208167B2 (en)	2000-08-07	2007-04-24	Sciclone Pharmaceuticals, Inc.	Treatment of hepatitis C with thymosin and peptide combination therapy
PT1311286E (pt) *	2000-08-07	2006-11-30	Sciclone Pharmaceuticals Inc	Combinação farmacêutica que contém timosina e interferão pegilado para o tratamento do hepatite c
BRPI0408892A (pt)	2003-03-28	2006-04-11	Sciclone Pharmaceuticals Inc	uso de timosina alfa 1 para tratar as infecções por arpergillus
US8337828B2 (en) *	2006-05-02	2012-12-25	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
EP2421970B1 (en) *	2009-04-24	2016-09-07	Roche Innovation Center Copenhagen A/S	Pharmaceutical compositions for treatment of hcv patients that are non-responders to interferon
EP2427213B1 (en)	2009-05-08	2015-04-01	Sciclone Pharmaceuticals, Inc.	Alpha thymosin peptides as vaccine enhancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1216056B (it) *	1988-03-11	1990-02-22	Sclavo Spa	Composizioni farmaceutiche contenenti timosina alfa 1.
TW224053B (fi) *	1991-09-13	1994-05-21	Paul B Chretien

1993
- 1993-09-27 CN CN93119345A patent/CN1072961C/zh not_active Expired - Lifetime
- 1993-12-27 JP JP5331601A patent/JPH06279309A/ja active Pending
1994
- 1994-02-18 MY MYPI94000381A patent/MY121198A/en unknown
- 1994-03-03 CA CA002157479A patent/CA2157479C/en not_active Expired - Fee Related
- 1994-03-03 EP EP94910226A patent/EP0687181B1/en not_active Expired - Lifetime
- 1994-03-03 KR KR1019950703297A patent/KR100306024B1/ko not_active IP Right Cessation
- 1994-03-03 DE DE69428112T patent/DE69428112T2/de not_active Expired - Lifetime
- 1994-03-03 AU AU62759/94A patent/AU683248B2/en not_active Ceased
- 1994-03-03 PT PT94910226T patent/PT687181E/pt unknown
- 1994-03-03 ES ES94910226T patent/ES2162862T3/es not_active Expired - Lifetime
- 1994-03-03 SG SG1996005604A patent/SG64894A1/en unknown
- 1994-03-03 WO PCT/US1994/002320 patent/WO1994020131A1/en active IP Right Grant
- 1994-03-03 DK DK94910226T patent/DK0687181T3/da active
- 1994-03-03 AT AT94910226T patent/ATE204760T1/de active
1995
- 1995-09-04 NO NO19953473A patent/NO320877B1/no not_active IP Right Cessation
- 1995-09-04 FI FI954127A patent/FI954127A/fi unknown
2001
- 2001-10-25 GR GR20010401892T patent/GR3037021T3/el unknown

Also Published As

Publication number	Publication date
GR3037021T3 (en)	2002-01-31
SG64894A1 (en)	1999-05-25
JPH06279309A (ja)	1994-10-04
KR100306024B1 (ko)	2001-11-30
ATE204760T1 (de)	2001-09-15
ES2162862T3 (es)	2002-01-16
CA2157479A1 (en)	1994-09-15
MY121198A (en)	2006-01-28
EP0687181A1 (en)	1995-12-20
NO953473D0 (no)	1995-09-04
DK0687181T3 (da)	2001-10-01
NO953473L (no)	1995-09-04
FI954127A (fi)	1995-09-04
WO1994020131A1 (en)	1994-09-15
CN1092322A (zh)	1994-09-21
DE69428112D1 (de)	2001-10-04
DE69428112T2 (de)	2002-03-21
CA2157479C (en)	2000-08-08
AU683248B2 (en)	1997-11-06
KR960700741A (ko)	1996-02-24
EP0687181B1 (en)	2001-08-29
CN1072961C (zh)	2001-10-17
NO320877B1 (no)	2006-02-06
PT687181E (pt)	2002-01-30
AU6275994A (en)	1994-09-26

Publication	Publication Date	Title
DK0858343T3 (da)	2004-05-10	Kontinuerlig lavdosis cytokininfusionsterapi
MY133891A (en)	2007-11-30	Polyethylene glycol modified interferon therapy
DE60237721D1 (de)	2010-10-28	Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
FI940919A (fi)	1994-04-25	Peptidejä sytotoksisen T-lymfosyyttivasteen indusoimiseksi hepatiitti B-virusta vastaan
EP0616535A4 (en)	1995-07-12	PROCESS FOR THE TREATMENT OF VIRAL INFECTIONS.
FI954127A0 (fi)	1995-09-04	Menetelmä C-hepatiitin hoitamiseksi interferonihoitoon reagoimattomissa potilaissa
ES2036526T3 (es)	1993-06-01	Composiciones de interferon.
HK1041215A1 (en)	2002-07-05	Use of thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir in manufacturing pharmaceutical combination preparations for treating hepatitis b infection.
CY1106388T1 (el)	2011-10-12	Θepαπεια ηπατιτιδας c με θυμοσινη, ιντepφepονη και ριβαβιρινη
OA08768A (fr)	1989-03-31	Traitement du virus su SIDA par l'interféron alpha humain recombinant.
DE60121449D1 (de)	2006-08-24	Behandlung von hepatitis c mit thymosin und pegyliertem interferon
RU98109203A (ru)	2000-02-10	Способ лечения вирусного гепатита b у детей
MY101495A (en)	1991-11-18	Treatment of diseases caused by viruses
TH33755A (th)	1999-07-09	การรักษาร่วมเพื่อขจัด hcv-rna ที่ตรวจหาได้ในผู้ป่วยที่ติดเชื้อตับอักเสบ c เรื้อรัง
MX9708885A (es)	1998-03-31	Uso de ribavirin e interferon alfa para el tratamiento de hepatitis c.